Skip Navigation
Heart & Vascular Institute
 
 
 
In This Section      
Print This Page

ARVD/C and Treatment with ICD

  • Schinkel AF. Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia/cardiomyopathy: patient outcomes, incidence of appropriate and inappropriate interventions, and complications. Circ Arrhythm Electrophysiol. 2013 Jun;6(3):562-8. 

  • James CA, Tichnell C, Murray B, Daly A, Sears SF, Calkins H. General and Disease-Specific Psychosocial Adjustment in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patients with Implantable Cardioverter Defibrillators: A Large Cohort Study. Circ Cardiovasc Genet. 2012 Jan 11. Read full article.
  • Bhonsale A, James CA, Tichnell C, Murray B, Gagarin D, Philips B, Dalal D, Tedford R, Russell SD, Abraham T, Tandri H, Judge DP, Calkins H. Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention. J Am Caoll Cardiol. 2011 Sep 27:58(14):1485-96. View abstract.
  • Bilchick KC, Judge DP, Calkins H, Marine JE. Use of a coronary sinus lead and biventricular ICD to correct a sensing abnormality in a patient with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Cardiovasc Electrophysiol. 2006 Mar;17(3):317-20. View abstract.
  • Piccini JP, Dalal D, Roguin A, Bomma C, Cheng A, Prakasa K, Dong J, Tichnell C, James C, Russell S, Crosson J, Berger RD, Marine JE, Tomaselli G, Calkins H. Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia. Heart Rhythm. 2005 Nov;2(11):1188-94. View abstract.
  • Roguin A, Bomma CS, Nasir K, Tandri H, Tichnell C, James C, Rutberg J, Crosson J, Spevak PJ, Berger RD, Halperin HR, Calkins H. Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol. 2004 May 19;43(10):1843-52. View abstract.
  • Roguin A, Zviman M, Meininger G, Rodríguez R, Dickfeld T, Bluemke D, Lardo A, Berger R, Calkins H, Halperin H. Modern Pacemaker and Implantable Cardioverter-Defibrillator Systems can be MRI safe: In-vitro and In-vivo assessment of safety and function at 1.5-Tesla. Circulation 2004;110(5):475-482. View abstract.
  • Roguin A, Bomma C, Nasir K, Tandri H, Tichnell C, James C, Rutberg J, Crosson J, Spevak J, Berger R, Halperin H, Calkins H. Implantable Cardioverter-Defibrillators in Patients with Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy. J Am Coll Cardiol 2004;43(10):1843-52. View abstract.

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.